Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1977 1
1980 3
1982 1
1984 2
1985 1
1986 4
1987 1
1988 2
1989 1
1991 1
1992 2
1993 2
1994 5
1995 4
1996 5
1997 5
1998 6
1999 4
2000 7
2001 6
2002 4
2003 7
2004 10
2005 8
2006 4
2007 5
2008 18
2009 18
2010 10
2011 11
2012 7
2013 14
2014 6
2015 5
2016 10
2017 10
2018 10
2019 8
2020 11
2021 6
2022 7
2023 8
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

236 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant trastuzumab in HER2-positive breast cancer.
Slamon D, Eiermann W, Robert N, Pienkowski T, Martin M, Press M, Mackey J, Glaspy J, Chan A, Pawlicki M, Pinter T, Valero V, Liu MC, Sauter G, von Minckwitz G, Visco F, Bee V, Buyse M, Bendahmane B, Tabah-Fisch I, Lindsay MA, Riva A, Crown J; Breast Cancer International Research Group. Slamon D, et al. N Engl J Med. 2011 Oct 6;365(14):1273-83. doi: 10.1056/NEJMoa0910383. N Engl J Med. 2011. PMID: 21991949 Free PMC article. Clinical Trial.
Immigrants and cancer in Italy: a literature review.
Crocetti E, Giuliani O, Ravaioli A, Bucchi L, Vattiato R, Falcini F. Crocetti E, et al. Among authors: ravaioli a. Ann Ist Super Sanita. 2017 Jul-Sep;53(3):238-245. doi: 10.4415/ANN_17_03_10. Ann Ist Super Sanita. 2017. PMID: 28956804 Free article. Review.
Prevalence of a BRCA2 Pathogenic Variant in Hereditary-Breast-and-Ovarian-Cancer-Syndrome Families with Increased Risk of Pancreatic Cancer in a Restricted Italian Area.
Zampiga V, Cangini I, Bandini E, Azzali I, Ravegnani M, Ravaioli A, Mancini S, Tebaldi M, Tedaldi G, Pirini F, Veneroni L, Frassineti GL, Falcini F, Danesi R, Calistri D, Arcangeli V. Zampiga V, et al. Among authors: ravaioli a. Cancers (Basel). 2023 Apr 3;15(7):2132. doi: 10.3390/cancers15072132. Cancers (Basel). 2023. PMID: 37046793 Free PMC article.
The descriptive epidemiology of melanoma in Italy has changed - for the better.
Bucchi L, Mancini S, Crocetti E, Dal Maso L, Baldacchini F, Vattiato R, Giuliani O, Ravaioli A, Zamagni F, Bella F, Bidoli E, Caldarella A, Candela G, Carone S, Carrozzi G, Cavallo R, Ferrante M, Ferretti S, Filiberti RA, Fusco M, Gatti L, Gili A, Iacovacci S, Magoni M, Mangone L, Mazzoleni G, Michiara M, Musolino A, Piffer S, Piras D, Rizzello RV, Rosso S, Rugge M, Scala U, Stracci F, Tagliabue G, Toffolutti F, Tumino R, Biggeri A, Masini C, Ridolfi L, Villani S, Palmieri G, Stanganelli I, Falcini F; Italian Melanoma Intergroup and the AIRTUM Working Group. Bucchi L, et al. Among authors: ravaioli a. Ital J Dermatol Venerol. 2023 Dec;158(6):483-492. doi: 10.23736/S2784-8671.23.07653-3. Ital J Dermatol Venerol. 2023. PMID: 38015485 Free article.
How a faecal immunochemical test screening programme changes annual colorectal cancer incidence rates: an Italian intention-to-screen study.
Bucchi L, Mancini S, Baldacchini F, Ravaioli A, Giuliani O, Vattiato R, Zamagni F, Giorgi Rossi P, Campari C, Canuti D, Di Felice E, Sassoli de Bianchi P, Ferretti S, Bertozzi N, Biggeri A, Falcini F; Emilia-Romagna Region Workgroup for Colorectal Screening Evaluation. Bucchi L, et al. Among authors: ravaioli a. Br J Cancer. 2022 Aug;127(3):541-548. doi: 10.1038/s41416-022-01813-7. Epub 2022 Apr 20. Br J Cancer. 2022. PMID: 35444286 Free PMC article.
Interpreting Breast International Group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer.
Regan MM, Price KN, Giobbie-Hurder A, Thürlimann B, Gelber RD; International Breast Cancer Study Group and BIG 1-98 Collaborative Group. Regan MM, et al. Breast Cancer Res. 2011 May 26;13(3):209. doi: 10.1186/bcr2837. Breast Cancer Res. 2011. PMID: 21635709 Free PMC article. Review.
Melanoma survival with Classification and Regression Trees Analysis: a complement for the communication of prognosis to patients.
Mancini S, Crocetti E, Bucchi L, Pimpinelli N, Vattiato R, Giuliani O, Ravaioli A, Baldacchini F, Balducci C, Stanganelli I, Falcini F. Mancini S, et al. Among authors: ravaioli a. Ital J Dermatol Venerol. 2021 Aug;156(4):460-466. doi: 10.23736/S2784-8671.19.06402-2. Epub 2019 Jun 17. Ital J Dermatol Venerol. 2021. PMID: 31210469 Free article.
236 results